Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change HSBC analysts downgraded Chubb Limited (NYSE:CB) from Buy to Hold on July 06, 2026. Market Context Chubb Limited operates in the Financial Services sector. The stock…
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Chubb Limited (NYSE:CB) on July 06, 2026. Market Context Chubb Limited operates in the Financial Services…
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Medtronic plc (NYSE:MDT) on July 06, 2026. Market Context Medtronic plc operates in the Healthcare…
Read moreRating Change Barclays analysts reiterated a Overweight rating on CrowdStrike Holdings, Inc. Class A Common Stock (NASDAQ:CRWD) on July 06, 2026. Market Context CrowdStrike…
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Stryker Corporation (NYSE:SYK) on July 06, 2026. Market Context Stryker Corporation operates in the…
Read moreRating Change HSBC analysts reiterated a Hold rating on The Progressive Corporation (NYSE:PGR) on July 06, 2026. Market Context The Progressive Corporation operates in the…
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Boston Scientific Corporation (NYSE:BSX) on July 06, 2026. Market Context Boston Scientific Corporation…
Read moreRating Change HSBC analysts downgraded Pfizer Inc. (NYSE:PFE) from Buy to Hold on July 06, 2026. Market Context Pfizer Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Neutral rating on Pfizer Inc. (NYSE:PFE) on July 06, 2026. Market Context Pfizer Inc.
Read moreRating Change HSBC analysts upgraded Gilead Sciences, Inc. (NASDAQ:GILD) from Hold to Buy on July 06, 2026. Market Context Gilead Sciences, Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD) on July 06, 2026. Market Context Gilead Sciences, Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Overweight rating on KLA Corporation (NASDAQ:KLAC) on July 06, 2026. Market Context KLA Corporation operates in the Technology…
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Danaher Corporation (NYSE:DHR) on July 06, 2026. Market Context Danaher Corporation operates in the…
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Uber Technologies, Inc. (NYSE:UBER) on July 06, 2026. Market Context Uber Technologies, Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on Intuitive Surgical, Inc. (NASDAQ:ISRG) on July 06, 2026. Market Context Intuitive Surgical, Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Abbott Laboratories (NYSE:ABT) on July 06, 2026. Market Context Abbott Laboratories operates in the…
Read moreRating Change JP Morgan analysts reiterated a Overweight rating on Citigroup Inc. (NYSE:C) on July 06, 2026. Market Context Citigroup Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on Citigroup Inc. (NYSE:C) on July 06, 2026. Market Context Citigroup Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Neutral rating on Amgen Inc. (NASDAQ:AMGN) on July 06, 2026. Market Context Amgen Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Overweight rating on Lam Research Corporation (NASDAQ:LRCX) on July 06, 2026. Market Context Lam Research Corporation operates…
Read more
